Ultrasound check of joints in mild hemophilia
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital clinical trials.
This study uses ultrasound to check the health of your joints. It aims to see if people with mild hemophilia have joint problems even without frequent bleeding, which could help guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with mild hemophilia (factor levels 5-40%).
- You are not currently on preventive treatment (like regular factor injections or emicizumab).
- You have not had a factor injection in the last 28 days.
- You do not have acquired hemophilia or a chronic inflammatory joint disease.
- You are not pregnant or breastfeeding, and you are not under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to check if thickened joint lining (synovium) in people with severe hemophilia is a sign of active inflammation or just a harmless leftover. It may help doctors decide whether to treat or watch these joints.
This study uses ultrasound to check if joints that are currently healthy stay healthy in people with hemophilia A who are taking emicizumab (Hemlibra) as their regular treatment. It aims to see if this treatment helps prevent joint damage over time.
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
This study looks at how many adults with moderate or severe hemophilia A have inflammation in their joints (synovitis). It aims to better understand joint health in people with hemophilia A, including those with inhibitors or joint replacements.
This study looks at tissue from joints affected by hemophilia to find new markers that could help understand and treat joint damage. It is for people with severe hemophilia who need a joint procedure like a fluid removal, synovectomy, or joint replacement.
Hear when a new Mild Hemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.